Activities, Bill Numbers and Titles
|
|
Client: Otsuka America Pharmaceutical, Inc.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $5,000.00
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
House Bill
|
1053
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
644
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
House Bill
|
2401
|
An Act relative to a kidney disease prevention and education task force
|
Support
|
$0.00
|
N/A
|
House Bill
|
1224
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
756
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1377
|
An Act to create a chronic kidney disease task force
|
Support
|
$0.00
|
N/A
|
House Bill
|
729
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|